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In this expert consensus statement of the Czech Society of Cardiology ofﬁcial guidelines
are given on how to assess cardiovascular patients' ﬁtness to drive motor vehicles
properly. The document also summarizes common legal framework on this topic in the
Czech Republic, e.g. the Act no. 297/2011 Coll. (so called Road Trafﬁc Act) and the Decree
no. 277/2004 Coll. on assessing medical ﬁtness to drive motor vehicles and draws attention
to some of the existing controversies.
& 2013 The Czech Society of Cardiology. Published by Elsevier Urban & Partner Sp.z o.o. All
rights reserved.
.1. Introduction
On 26 April, 2004, the Ministry of Health of the Czech Republic
issued Decree no. 277 on assessing medical ﬁtness to drive
motor vehicles, medical ﬁtness to drive motor vehicles only if a
prerequisite is met, and formalities of physician's note certify-
ing medical reasons that justify the non-use of seat belt whilech Society of Cardiology.
aortic valve area; CABG
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Hradec).riding/driving a motor vehicle [1], in short, the Decree on
Medical Fitness to Drive Motor Vehicles. The decree came into
effect on 1 June, 2004. The purpose thereof was to harmonize
Czech laws with the law of the European Union.
Pursuant to Section 6 of the Decree, an assessing physician
(usually the General Practitioner the person assessed is
registered with) may request an expert examination. ThePublished by Elsevier Urban & Partner Sp.z o.o. All rights reserved.
, coronary artery bypass grafting; CNS, central nervous system;
ase; IVS, interventricular septum; LAH, left anterior hemiblock;
left ventricular ejection fraction; LVOT, left ventricular outﬂow
dial infarction; NYHA, New York Heart Association;
taneous coronary intervention; RBBB, right bundle branch block;
.
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whenever the person assessed is under constant care of a
specialist treating conditions that disqualify a person from
driving motor vehicles or restrict one's medical ﬁtness thereto.
The expert examination has to conclude by assessing medical
ﬁtness of the person assessed to drive motor vehicles in relation
to the scope of the expert examination carried out and specify-
ing a prerequisite under which a person is allowed to drive
motor vehicles, if applicable. Should the suggested prerequisite
consist in undergoing a reassessment, the expert examination
has to conclude by specifying a date by which the person
assessed is to undergo such reassessment. The physician
carrying out the expert examination shall record conclusions
based on his/her ﬁndings and examinations or expert opinions
in their entirety in the medical records that he/she keeps. The
expert report on medical ﬁtness to drive motor vehicles has to
be unambiguous and must not provide any disease diagnosis,
and the assessing physician has to attach his/her signature, his/
her name stamp, the stamp of the health care provider and the
date of the issue thereof. For an expert report form see Annex
no. 1 to Decree no. 277 [1].
Annex no. 3 to the Decree lists diseases, defects and
conditions disqualifying a person from driving motor vehicles
or restricting one's medical ﬁtness to do so only if a pre-
requisite is met. Part IV lists diseases, defects and conditions
of the circulatory system disqualifying a person from
driving motor vehicles or restricting one's medical ﬁtness to
do so only if a prerequisite is met. The list of diseases, defects
and conditions speciﬁed in Annex 3 to the Decree is rather
general, indeﬁnite and contains no quantitative parameters;
it is even confusing in some parts. There are diseases and
conditions such as severe forms of chronic obstructive
pulmonary disease with global respiratory insufﬁciency, cer-
ebrovascular diseases and subsequent disorders, conditions
following cerebrovascular accidents with serious limitation of
bodily and/or mental functions and transient ischemic
attacks included in the list of circulatory diseases despite
the fact that these are not treated by cardiologists. It also
shows nonsense in terms of medical accuracy, such as the
ban on driving motor vehicles imposed on commercial
drivers with a permanent pacemaker implant [1].
The Czech Society of Cardiology (ČKS) responded to the
issue of the Decree by issuing its own recommendation
concerning the assessment of cardiac patients for ﬁtness to
drive motor vehicles [2], which was also published as a
pocket-sized book [3]. The Recommendation was based on
experience from abroad, following the example of the Cana-
dian Cardiovascular Society (CCS), in particular, since CCS has
been issuing such directives since 1992 [4–6].2. Legislative changes in 2012
Some of the provisions of Act no. 297/2011 Coll., amending Act
no. 361/2000 Coll., on Operation of Vehicles on Roadways (or the
Road Trafﬁc Act), came into effect on 1 January, 2012. Newly
added Section 89a coming into effect on 1 January, 2012, is the
key provision concerning physicians, stipulating the following:
“Any physician who ascertains that a person applying for a driving
licence or a driving licence holder is medically ﬁt to drive motorvehicles only if a prerequisite is met, or that he/she is medically unﬁt
to drive motor vehicles, shall be obliged to report this fact to a locally
competent municipal authority of a municipality with extended
competence depending on the habitual residence or place of studies
of the person applying for driving licence or the driving licence holder
without delay.” [7].
The Ministry of Transport of the Czech Republic was the
sponsor of the bill. According to information provided by this
ministry, there is no prescribed manner in which to report
changes in patient's medical condition and no corresponding
blank form has been issued either. It is therefore sufﬁcient to
report to the competent municipal authority of a municipality
with extended competence by way of a letter containing the
identiﬁcation of the patient and the conclusion of physician's
expert report stating that, according to the physician's expert
ﬁndings, the patient is unﬁt to drive motor vehicles, or he/she is
ﬁt to do so only if a prerequisite is met, specifying such
prerequisite. Subsequently, the specialist should inform the
General Practitioner the patient is registered with of the medical
reasons in amedical report. A copy of the letter should be ﬁled in
the patient's medical records for future reference proving that
the physician performed his duty. The new duty to report under
Section 89a of the Act applies to physicians of all specializations
as soon as they ascertain relevant changes in patient's medical
condition. Based on the report provided by a physician, a
municipal authority shall initiate administrative proceedings ex
ofﬁcio, which may result in suspending a driving licence tem-
porarily or taking it away permanently. At the same time, the
municipal authority as an administrative body shall order the
driver to undergo a reassessment of his/her medical ﬁtness to
drive motor vehicles within a set deadline. The driver shall ﬁle
his/her application for the reassessment of his/her medical
condition with the General Practitioner he/she is registered with,
or his/her corporate preventative care physician, or any other
General Practitioner if he/she is not registered with any (Section
84, paragraph 4 of the Act). The reassessment shall either claim
that, despite the ﬁndings, the patient did not lose his/her ﬁtness
to drive, or, on the other hand, that patient's ﬁtness to drive is
restricted or he/she is disqualiﬁed from driving in his/her current
medical condition. Pursuant to Section 86 of the Act, the General
Practitioner shall report this fact to the municipal authority of a
municipality with extended competence in the way he/she has
been doing in the case of expert reports [8].
Before the amendment came into effect, an assessing phy-
sician has had a duty to report under Section 86 of the Act all
along. The assessing physician was either a General Practitioner
the patient was registered with, or a corporate preventative care
physician, or any other General Practitioner if a person was not
registered with any. As a consequence, a cardiologist or an
internist running cardiology practice had no direct duty to
report in relation to authorities. It was the assessing physicians
who would report to authorities one's unﬁtness to drive motor
vehicles or their ﬁtness to do so only if a prerequisite is met.
Pursuant to Section 10 of Decree no. 277/2004 Coll., a specialist
has had a duty, however, to inform the driver and the assessing
physician, if he/she was known to him/her, of a driver's
unﬁtness to drive motor vehicles in writing [1]. The addition of
Section 89a in the amendment of Act no. 361/2000 Coll., the
Road Trafﬁc Act, resulted in imposing the duty to report on all
physicians of all medical specialties.
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raised a number of issues, as well as legal interpretations
concerning the amendment, such as what exactly is an applying
person's habitual residence (place of studies) in terms of the locally
competent authority, or how exactly is a physician supposed to
learn that his/her patient is a driving licence holder if the patient
does not inform him/her accordingly. Reporting to a competent
authority without delay poses another problem. Some medical
reasons resulting in one's unﬁtness to drive motor vehicles or in
one's restricted ﬁtness to do so only if a prerequisite is met, are
temporary (of temporary nature) only. ČKS's Recommendation
has expressed such temporariness by introducing a Waiting
Period [2,3]. In some cases, the waiting period is very short, e.g.
1 week in the case of private drivers after PCI for acute coronary
syndrome, or, similarly, after the insertion of a permanent
pacemaker. In such a short period of time, hardly can a
competent authority receive a report, let alone respond accord-
ingly. Even if the authority does respond, it usually occurs when
the physician report is no longer substantiated since the waiting
period has elapsed. The fact that a patient/driver is not entitled
to ﬁle an application for any remedial measure against the report
made to a municipal authority without delay pursuant to Section
89a of the Road Trafﬁc Act raises another serious issue. An
obligatory formality of an expert report on patient's medical
condition consists in the advice on appeal, i.e. advising the
patient (to whom an expert report has to be delivered) in which
cases he/she is entitled to appeal against the expert report, or
his/her right to lodge an appeal for the review of the expert
report in question within 15 days of the delivery thereof to the
patient. Thus the duty to report without delay pursuant to Section
89a of the Act and patient's right to be informed and his/her
right to appeal against an expert report on his/her medical
condition conﬂict with each other.
No amendment has been made to Decree no. 277/2004
Coll. on Assessing Medical Fitness to Drive Motor Vehicles
whatsoever, and Annex 3 thereto – Diseases, defects or
conditions disqualifying from driving motor vehicles or
restricting medical ﬁtness to do so only if a prerequisite is
met – has been updated only imperceptibly in parts concern-
ing sight, diabetes mellitus and epilepsy up to now. Part IV of
the Annex listing disqualifying cardiovascular diseases has
not been amended at all. As mentioned above, the deﬁnitions
of such disqualifying cardiovascular diseases and conditions
contained in Annex no. 3 to the Decree are extremely vague
and general. In some cases, Annex no. 3 to the Decree [1] and
ČKS's 2006 Recommendation [2,3] conﬂict with each other.
Speciﬁcally, this concerns permanent cardiostimulation,
which, according to the Annex to the Decree, disqualiﬁes
commercial drivers from driving! Sadly, despite a clear non-
sense in terms of medical accuracy, it is the Decree of the
Ministry of Health that is binding, not a procedure recom-
mended by a professional society.3. Cardiology development calling for
professional changes
Ventricular arrhythmias, a signiﬁcant group of cardiovascular
diseases, pose a threat to a patient/potential driver, since he/
she may lose consciousness or die suddenly. That is why theAmerican Heart Association issued and published an all-
embracing scientiﬁc statement on private and public safety
issues related to possible loss of consciousness in arrhythmia
as early as 1996 [9]. This statement also contains recommen-
dation concerning the driving of motor vehicles by patients
who survived a life-threatening arrhythmia – a permanent
ventricular tachycardia (PVT) or a ventricular ﬁbrillation (VF)
– and who had an implantable cardioverter deﬁbrillator (ICD)
implanted on the secondary prophylaxis level. Since then,
several randomized clinical studies have proved the impor-
tance of ICD for the prophylaxis of a sudden heart death and
the reduction of the risk of life-threatening ventricular
arrhythmias also on the primary prophylaxis level. Based
on the results of these studies, the percentage of patients
who had ICD implanted on the primary prophylaxis level
(i.e. patients with high risk of occurrence of a life-threatening
arrhythmia who had, however, experienced no PVT or VF yet)
has been increasing rapidly. The original American recom-
mendation took into consideration patients with ICD
implanted on the secondary prophylaxis level only, just as a
similar 1997 recommendation of a responsible working group
of the European Society of Cardiology did [10]. Based on these
statements and recommendations, rather strict restrictions
for driving motor vehicles were applied in all patients with
implanted ICD, regardless of the fact whether the implanta-
tion was carried out on the secondary or primary prophylaxis
level. For that matter, ČKS's 2006 Recommendation has not
taken into consideration the reasons for an ICD implant
either [1].
Patients with ICD have a higher risk of sudden indisposi-
tion, sudden impairment of consciousness or even sudden
cardiac death and they may pose a threat to themselves, as
well as the others while driving. It has to be emphasized,
however, that it is the primary cardiovascular disease that
presents such a risk, not the ICD itself. Previous recommen-
dations, be it the Czech [1], American [9] or European [10]
ones, are still appropriate in patients with ICD implanted on
the secondary prophylaxis level following an episode of PVT
or VF and there is no need to change the recommendations
concerning these patients. Nevertheless, these previous
recommendations are not appropriate in patients with ICD
implanted on the primary prophylaxis level (prophylactic
implant). The previous American [11] and European [12]
recommendations have been updated accordingly; there is
no question of the need to amend ČKS's Recommendation in
this sense as well.4. ČKS's activities
Well aware of considerable difﬁculties brought on cardiolo-
gists by the legislative changes, i.e. the amendment of Act no.
361/2000 Coll. (the newly added Section 89a) speciﬁcally, as
well as Annex no. 3 to Decree of the Ministry of Health no.
277/2004 Coll., both unsatisfactory in terms of medical accu-
racy, ČKS's Board nominated a working group that was
charged with the task of updating ČKS's expert consensus
statement concerning the assessment of cardiac patients for ﬁtness
to drive motor vehicles and, in cooperation with the Board,
c o r e t v a s a 5 5 ( 2 0 1 3 ) e 2 1 7 – e 2 2 4e220trying to press such legislative changes that would eliminate
the existing contradictions and opacities.
We took the opportunity of a joint meeting of ČKS's
representatives with Mr. Leoš Heger, MD., CSc., MBA, the
Minister of Health of the Czech Republic, and some of his co-
workers held on 21 May, 2012, to promote the legislative
changes in question. The legislative changes concerning the
assessment for ﬁtness to drive motor vehicles were one of the
points on the agenda that we managed to push through in
the meeting. Mr. Ferdinand Polák, MD., PhD., the Deputy
Minister of Health Care, agreed to assist in updating Decree
no. 277/2004 Coll., which is in competence of the Ministry of
Health. Consequently, Deputy Minister Polák informed us in
his letter dated 13 June, 2012, that “as to Section 89a, our
ministry shall demand that the Ministry of Transport change
it or delete it entirely”. He also thanked for the offer made by
ČKS to cooperate in the updating of Decree no. 277/2004 Coll.,
or, more speciﬁcally, of Annex no. 3 thereto, Part IV listing
diseases, defects or conditions of the circulatory system
disqualifying a person from driving motor vehicles or restrict-
ing one's medical ﬁtness to do so only if a prerequisite is met,
which he accepted.
In this ČKS expert consensus statement, we submit guide-
lines on how to assess patients' ﬁtness to drive motor vehicles
properly. This scientiﬁc statement will also provide basis for our
negotiations with the competent department of the Ministry of
Health of the Czech Republic over the amendment to Decree no.
277/2004 Coll., speciﬁcally, Part IV of Annex no. 3 thereto.5. Deﬁnitions of terms
For the purpose of this document, the deﬁnition of a private
driver shall correspond to the deﬁnition of a person applying
for and a holder of driving licence—group 1 pursuant to
Annex no. 3 to Decree no. 277, and the deﬁnition of a
commercial driver shall correspond to the deﬁnition of a
person applying for and a holder of driving licence—group 2
pursuant to Annex no. 3 to Decree no. 277 [1].
Private driver: a driver driving a motor vehicle for his/her
individual needs, the weight of the motor vehicle not exceed-
ing 10 t. Pursuant to Decree of the Ministry of Health of the
Czech Republic no. 277 Coll., this shall include persons
applying for and holders of driving licence—groups A, B, B
+E, AM, and subgroups A1 and B1.
Commercial driver: any driver who does not fulﬁll the
deﬁnition of a private driver. Pursuant to Decree of the
Ministry of Health of the Czech Republic no. 277 Coll., this
shall include the following:(a) drivers driving a motor vehicle in employment relation,
(b) drivers using a special warning blue light when driving,(c) drivers in whom driving of a motor vehicle constitutes the
object of their independent gainful activity,(d) persons applying for and holders of a certiﬁcate for
driving instructors for training in the driving of motor
vehicles, and(e) persons applying for and holders of driving licence—
groups C, C+E, D, D+E, T, and subgroups C1, C1+E, D1,
D1+E.Waiting period: a time interval following the onset (diag-
nosis) of a limiting or disqualifying cardiovascular disease or
condition, or the initiation of treatment or the performance of
a therapeutic procedure, during which a driver is disqualiﬁed
from driving a motor vehicle for medical reasons or is able to
do so only if a prerequisite is met.
Recurrence of a disqualifying cardiovascular disease or
condition resets the waiting period. Should several waiting
periods apply when assessing an applicant or driver, the
longest waiting period shall be used.
NYHA functional classiﬁcation:Class I No functional limitation. A patient is able to
achieve seven METs without showing signs
(shortness of breath, fatigue, chest pain) or
objective symptoms of heart dysfunction.Class II Mild functional limitation, working capacity 5–
7 METs.Class III Marked functional limitation, working
capacity 2–4 METs.Class IV Severe functional limitation, symptoms of
heart dysfunction at rest or at minimal
physical activity, working capacity not
exceeding 2 METs.Functional classiﬁcation may be made on the basis of a
clinical assessment; however, a classiﬁcation of the working
capacity based on a stress test is more accurate.
The Metabolic Equivalent of Task (MET): one MET is the
resting oxygen consumption in the seated position and is
equivalent to 3.5 mL/kg/min.
Stress test: bicycle ergometry, treadmill ergometry, exercise
and pharmacologic stress echocardiography, thallium
stress test.
Symptoms of CNS hypoperfusion: transient quantitative or
qualitative impairment of consciousness, sight disorder, loss
of muscular tonus or other neurological symptoms of
decreased blood ﬂow in CNS.
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Should the ﬁtness to drive a motor vehicle be subject to various prerequisites, all of these have to be met.Private driver Commercial driverI. Arterial hypertension
(a) Uncomplicated hypertension,
controlled by treatmentNo restrictions(b) Malignant hypertension, hypertension
with organ alterations resulting in organ
failure NYHA Functional Class I-III
 Annual reassessmentDisqualiﬁedII. Ischemic heart disease (IHD)
1. General prerequisites Applicable waiting period (see below)  Applicable waiting period
 Functional class I-II
 LVEF≥0.402. Speciﬁc prerequisites
(a) Asymptomatic IHD No restrictions
(b) Stable angina pectoris (AP) No restrictions
(c) Acute coronary syndromes (MI, UA),
untreated by PCI or STEMI treated by
primary PCI or thrombolysisWaiting period 1 month  Waiting period 3 months
 Reassessment with stress test in
6 months(d) UA and NSTEMI treated by PCI Waiting period 1 week  Waiting period 1 month
 Reassessment with stress test in
6 months(e) Coronary artery bypass graft surgery
(CABG)Waiting period 1 month Waiting period 3 monthsIII. Heart failure, dilated cardiomyopathy
NYHA functional class I–II No restrictions  LVEF≥0.40
 No ventricular tachycardia on
Holter monitoring (both sustained
and non-sustained)
 Annual reassessmentNYHA functional class III  No restrictions
 Annual reassessmentDisqualiﬁedNYHA functional class IV DisqualiﬁedIV. Arrhythmias
1. Ventricular arrhythmias
General prerequisite: Arrhythmia examination in a Complex Cardiovascular Centre (pursuant to the Journal of the Ministry of
Health of the Czech Republic) with a standard arrhythmia management (clinical examination, non-invasive diagnostics,
electrophysiology study, ICD implant, catheter ablation, surgical treatment of the substrate, etc.).
Speciﬁc prerequisites:
(a) Condition following ventricular
ﬁbrillation or hemodynamically signiﬁcant
ventricular tachycardia, excluding
transitory causes* Provision of ICD
 Waiting period 3 monthsDisqualiﬁed
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in patients with LVEFo0.35  Waiting period 3 months(c) Documented sustained ventricular
tachycardia, hemodynamically tolerated,
in patients with LVEF≥0.40 Catheter ablation or antiarrhythmic
therapy
 Repeated ECG check on Holter
monitoring
 Waiting period 3 months
 If the treatment shows ineffective,
provision of ICD plus waiting period
3 months Catheter ablation or
antiarrhythmic therapy
 Repeated ECG check on Holter
monitoring
 Waiting period 6 months
 If the treatment is shown to be
ineffective, provision of ICD plus
ban on driving(d) Non-sustained ventricular tachycardia
in patients with LVEF≥0.40No restrictions Examination once a year
individualized treatment*Examples of reversible cause of ventricular ﬁbrillation: within 24 h of the onset of myocardial infarction, in the course of coronary
angiography, in electrical injuries, secondary to drug toxicity, etc.
2. Supraventricular arrhythmias
(a) Paroxysmal supraventricular
tachycardia, atrial ﬁbrillation and ﬂutter
with symptoms of CNS ischemiaSuccessful catheter ablation plus corresponding waiting period (see Part IV
(6)) or successful pharmacotherapy plus waiting period 3 months without the
recurrence of arrhythmia(b) Paroxysmal supraventricular
tachycardia, atrial ﬁbrillation and ﬂutter
without symptoms of CNS ischemiaNo restrictions
In paroxysmal atrial ﬁbrillation/ﬂutter chronic anticoagulation clinically
indicated(c) Persistent or permanent atrial
ﬁbrillation and ﬂutter with adequate
ventricular rate control and without
symptoms of CNS ischemiaNo restrictions.
Chronic anticoagulation clinically indicated3. Conduction abnormalities
(a) Isolated ﬁrst-degree AV block No restrictions
Isolated right
bundle branch block (RBBB)Isolated fascicular block -
left anterior hemiblock (LAH)
or left posterior hemiblock (LPH)(b) Left bundle branch block (LBBB)
Bifascicular block
Second-degree AV block (Mobitz I) No restrictions Annual reassessment plus Holter
monitoring(c) Higher-degree AV block without the
provision of permanent cardiostimulationDisqualiﬁed4. Permanent pacemaker
Applicable to all patients following the
implantation Waiting period 1 week
 Normal function of the pacemaker
 Regular check-ups in a device clinic,
at least once a year, or in
combination with remote
monitoring. Waiting period 1 month
 Normal function of the pacemaker
 Regular check-ups in a device
clinic, at least once a year, or in
combination with remote
monitoring.5. Implantable cardioverter-deﬁbrillator (ICD)
General prerequisites  Applicable waiting period—see below
 Regular check-ups in a device clinic
Disqualiﬁed
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combination with remote
monitoring of ICD
 Proper functioning of ICD system
 NYHA Functional classiﬁcation I–IIISecondary prophylaxis Waiting period 3 months
Primary prophylaxis Waiting period 1 month
Following ICD appropriate electrical shock Waiting period 3 months
Following ICD inappropriate electrical
shockWaiting period until the cause of the
inappropriate electrical shock is dealt
withFollowing ICD replacement Waiting period 1 week
Following a replacement of the system of
electrodesWaiting period 1 month6. Catheter ablation
Waiting period 1 weekV. Syncope
(a) Single episode of typical No restrictions
vasovagal syncope
(b) Recurrent (within 12 months) vasovagal
syncope or single episode of unexplained
syncopeWaiting period 1 month Waiting period 1 year(c) Recurrent (within 12 months) episode of
unexplained syncopeWaiting period 1 year(d) Syncope—diagnosed and successfully
treated cause (e.g. permanent pacemaker
implant for bradyarrhythmia)Waiting period 1 week Waiting period 1 month(e) Situational syncope of avoidable trigger
(e.g. micturition syncope, defecation
syncope)Waiting period 1 week(f) Syncope—reversible cause (e.g.
hemorrhage or dehydration)Successful treatment of the cause(g) Syncope due to documented
tachyarrhythmia or inducible
tachyarrhythmia at an electrophysiology
studySee Part IV (2) (a)VI. Valvular heart disease
(a) Aortic valve stenosis  NYHA Functional Class I–II
 Without symptoms of CNS
hypoperfusion
 Annual reassessment NYHA Functional Class I–II
 Without symptoms of CNS
hypoperfusion
 LVEF≥0.55
 AVAI≥1.0 sq cm/sq m
 No ventricular tachycardia on
Holter monitoring
 Annual reassessment(b) Aortic insufﬁciency or  NYHA functional classes I–II
 Without symptoms of CNS
hypoperfusion
 Annual reassessment NYHA functional classes I–II
 Without symptoms of CNS
hypoperfusion
 LVEF≥0.55
 No ventricular tachycardia on
Holter monitoring
 Annual reassessmentMitral valve stenosis or
Mitral insufﬁciency
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bioprostheses) NYHA Functional classes I–II
 Waiting period 3 months
 Anticoagulation therapy in
mechanical prostheses
 No thromboembolic complications
 Annual reassessment Waiting period 6 months
 Anticoagulation therapy in
mechanical prostheses
 No thromboembolic complications
 NYHA Functional Class I–II
 LVEF≥0.55
 No ventricular tachycardia on
Holter monitoring
 Annual reassessmentVII. Hypertrophic cardiomyopathy
Applicable to all patients  Without symptoms of CNS
hypoperfusion
 No ventricular tachycardia on Holter
monitoring
 Reassessment in 2 years Without symptoms of CNS
hypoperfusion (no history of
symptoms of CNS hypoperfusion
either)
 No family history of sudden death
at a younger age
 No ventricular tachycardia on
Holter monitoring
 No blood pressure decrease with
exercise
 LV wall and/or IVS
thicknesso20 mm
 No LVOT obstruction
 Annual reassessmentVIII. Heart transplant
Applicable to all patients  Waiting period 3 months
 NYHA Functional Class I–II
 Annual reassessment Waiting period 1 year
 NYHA Functional Class I
 LVEF≥0.40
 Annual reassessment including
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